Risk‐adapted management of low‐grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)-Reference-Cited by-同舟云学术

Risk‐adapted management of low‐grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)

Published:2020-02-08 Issue:4 Volume:125 Page:497-505
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Matulay Justin T.¹^ORCID,Soloway Mark²,Witjes J. Alfred³,Buckley Roger⁴,Persad Raj⁵,Lamm Donald L.⁶,Boehle Andreas⁷,Palou Joan⁸,Colombel Marc⁹,Brausi Maurizio¹⁰,Kamat Ashish M.¹

Affiliation:

1. University of Texas MD Anderson Cancer Center Houston TX USA

2. Memorial Cancer Institute Memorial Hospital Hollywood FL USA

3. Radboud University Nijmegen Medical Centre Nijmegen the Netherlands

4. North York General Hospital Toronto Ontario Canada

5. Bristol Royal Infirmary and Bristol Urological Institute Bristol UK

6. University of Arizona and BCG Oncology Phoenix AZ USA

7. University of Luebeck Luebeck Germany

8. Fundació Puigvert Universitat Autònoma de Barcelona Barcelona Spain

9. Claude Bernard University Hôpital Edouard Herriot Lyon France

10. Azienda Unità Sanitaria Locale di Modena Modena Italy

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.14995

Reference56 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. It Is Time to Abandon the “Superficial” in Bladder Cancer

3. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

4. Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

5. A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-Escalation of Therapy for Low-Grade Papillary Bladder Tumors With Preserved Long-Term Oncologic Outcomes;Urology Practice;2024-09

2. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG);European Urology Oncology;2024-08

3. Efficacy and safety of office-based diode laser ablation for recurrent low-grade non-muscle-invasive bladder cancer under local anaesthesia: A pilot study;Arab Journal of Urology;2024-07-18

4. Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma;Journal of Translational Medicine;2024-07-02

5. The clinical effect of gratitude extension-construction theory nursing program on bladder cancer patients with fear of cancer recurrence;Frontiers in Oncology;2024-04-30